Skip to main content
Clinical Trials/TCTR20230222009
TCTR20230222009
Completed
Phase 1

Study on the efficacy of a synergetic supplement of five edible plant extracts on telomere length in adults

Asian Phytoceuticals Public Company Limited0 sites32 target enrollmentFebruary 22, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Thai male and female age 50-65 y have stable health status by using fix dose of blood pressure medications or lipid- lowering medication without serious symptoms.
Sponsor
Asian Phytoceuticals Public Company Limited
Enrollment
32
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2023
End Date
November 21, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Body mass index 20\-24\.9 kg/m2
  • 2\.Had stable health status by using fix dose of blood pressure medications or lipid\- lowering medication without serious symptoms

Exclusion Criteria

  • 1\. Female went through menopause for less than 6 months.
  • 2\. Type 2 DM
  • 3\. Renal diseases
  • 4\. Hepatic diseases
  • 5\. Thyroid disorder
  • 8\. Pregnant women
  • 9\. Lactating women
  • 10\. Take any supplements in the pass 1 month
  • 11\. Injected vaccine in the pass 1 month
  • 12\. Infected with COVID 19 in the pass 1 month

Outcomes

Primary Outcomes

Not specified

Similar Trials